Neogenomics Inc (NASDAQ:NEO)

9.27
Delayed Data
As of Apr 20
 +0.05 / +0.54%
Today’s Change
7.08
Today|||52-Week Range
11.63
+4.63%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +18.66% increase from the last price of 9.27.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.04
Sales
$67.1M
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.29%
 
 
 
 
 
 
Growthannually 32.48%
 
 
 
 
 
 

Sales

Growthquarterly -1.01%
 
 
 
 
 
 
Growthannually 2.83%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.